MDT
88.44
-1.53%↓
VEEV
227.74
-1.64%↓
A
113.65
-2.76%↓
HQY
87.08
-1.46%↓
PDCO
31.26
0%↓
MDT
88.44
-1.53%↓
VEEV
227.74
-1.64%↓
A
113.65
-2.76%↓
HQY
87.08
-1.46%↓
PDCO
31.26
0%↓
MDT
88.44
-1.53%↓
VEEV
227.74
-1.64%↓
A
113.65
-2.76%↓
HQY
87.08
-1.46%↓
PDCO
31.26
0%↓
MDT
88.44
-1.53%↓
VEEV
227.74
-1.64%↓
A
113.65
-2.76%↓
HQY
87.08
-1.46%↓
PDCO
31.26
0%↓
MDT
88.44
-1.53%↓
VEEV
227.74
-1.64%↓
A
113.65
-2.76%↓
HQY
87.08
-1.46%↓
PDCO
31.26
0%↓
24h
Praegune
Min
1.47
Max
1.55
Soovitused | Osta |
---|---|
12 kuu keskmine prognoos | +938.96% upside |
Järgmine tulemuste avaldamine | 2. apr 2025 |
---|
Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.
10. märts 2025, 02:12 UTC
Checkpoint Controlling Shareholder Fortress Has Agreed to Vote in Favor of Transaction >524715.BY
DJ
Loe
10. märts 2025, 02:12 UTC
Sun Pharma, Checkpoint Transaction Expected to Complete in 2Q 2025 >524715.BY
DJ
Loe
10. märts 2025, 02:11 UTC
Sun Pharma, Checkpoint, Fortress Biotech Enter Into Royalty Agreement >524715.BY
DJ
Loe
10. märts 2025, 02:11 UTC
Checkpoint Shareholders Entitled to Receive Up to Additional $0.70 if Cosibelimab if Approved in EU Prior to Certain Deadlines >524715.BY
DJ
Loe
10. märts 2025, 02:10 UTC
Checkpoint Shareholders to Receive Upfront Cash Payment of $4.10/Share, Contingent Value Right >524715.BY
DJ
Loe
10. märts 2025, 02:10 UTC
Sun Pharma to Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Loe
10. märts 2025, 02:06 UTC
Sun Pharma To Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Loe
Hinnamuutus
By TipRanks
12 kuu keskmine prognoos
Keskmine 16 USD 938.96%
Kõrge 16 USD
Madal 16 USD
Põhineb 1 Wall Streeti analüütiku instrumendi Fortress Biotech Inc 12 kuu hinnasihil - viimase 3 kuu andmed.
By TipRanks
Osta
1 ratings
1
Osta
0
Hoia
0
Müü
Põhineb 1 analüütiku instrumendi Fortress Biotech Inc aktsia reitingul - viimase 3 kuu andmed.
$